Chirag Dagli
Fund manager Chirag Dagli: portfolio changes across the 2 schemes AMFI's scheme summary documents name them on, Oct 2026, by share count.
Equity.
2 with AMFI average AUM, July - September 2026; each scheme in full, not split between co-managers. Source: AMFI.
On a scheme named on today, as the fund house files it. Source: AMFI SSD.
People named on at least one of the same schemes.
| Scheme | Fund house | Category | AUM | Role, as filed | Since, as filed | As of |
|---|---|---|---|---|---|---|
| DSP Healthcare Fund | DSP Mutual Fund | Equity Schemes - Sectoral Fund | ₹3,721 cr | — | — | 2 Nov 2026 |
| DSP Multi Cap Fund | DSP Mutual Fund | Equity Schemes - Multi Cap Fund | ₹2,974 cr | — | — | 2 Nov 2026 |
From each scheme's summary document on AMFI's site (scheme details), as it stood on the date shown. How to read
- ₹356 cr
- ₹330 cr
- ₹327 cr
- ₹315 cr
- ₹276 cr
- ₹273 cr
- ₹269 cr
- ₹180 cr
- ₹173 cr
- ₹165 cr
| Ticker | Company | Value | % of equity held | Schemes holding |
|---|---|---|---|---|
| CIPLA | Cipla Limited | ₹356 cr | 6.0 % | 2 |
| APOLLOHOSP | Apollo Hospitals Enterprise Limited | ₹330 cr | 5.6 % | 2 |
| IPCALAB | IPCA Laboratories Limited | ₹327 cr | 5.5 % | 2 |
| GLAND | Gland Pharma Limited | ₹315 cr | 5.3 % | 2 |
| SAILIFE | Sai Life Sciences Limited | ₹276 cr | 4.7 % | 2 |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹273 cr | 4.6 % | 1 |
| ALKEM | Alkem Laboratories Limited | ₹269 cr | 4.6 % | 2 |
| HDFCBANK | HDFC Bank Limited | ₹180 cr | 3.0 % | 1 |
| COHANCE | Cohance Lifesciences Limited | ₹173 cr | 2.9 % | 2 |
| DIVISLAB | Divi's Laboratories Limited | ₹165 cr | 2.8 % | 1 |
| ICICIBANK | ICICI Bank Limited | ₹164 cr | 2.8 % | 1 |
| APLLTD | Alembic Pharmaceuticals Limited | ₹125 cr | 2.1 % | 2 |
| AXISBANK | Axis Bank Limited | ₹108 cr | 1.8 % | 1 |
| ICICIGI | ICICI Lombard General Insurance Company Limited | ₹108 cr | 1.8 % | 2 |
| THYROCARE | Thyrocare Technologies Limited | ₹106 cr | 1.8 % | 1 |
The 15 largest holdings by market value, summed over the schemes this manager is named on today.
| Ticker | Company | Schemes holding | Value |
|---|---|---|---|
| CIPLA | Cipla Limited | 2 | ₹356 cr |
| APOLLOHOSP | Apollo Hospitals Enterprise Limited | 2 | ₹330 cr |
| IPCALAB | IPCA Laboratories Limited | 2 | ₹327 cr |
| GLAND | Gland Pharma Limited | 2 | ₹315 cr |
| SAILIFE | Sai Life Sciences Limited | 2 | ₹276 cr |
| ALKEM | Alkem Laboratories Limited | 2 | ₹269 cr |
| COHANCE | Cohance Lifesciences Limited | 2 | ₹173 cr |
| APLLTD | Alembic Pharmaceuticals Limited | 2 | ₹125 cr |
| ICICIGI | ICICI Lombard General Insurance Company Limited | 2 | ₹108 cr |
| SYNGENE | Syngene International Limited | 2 | ₹104 cr |
| INDOCO | Indoco Remedies Limited | 2 | ₹83.5 cr |
Every stock held by 2 or more of this manager's schemes today, whatever its value — not limited to the largest-holdings list above.
2 schemes have no filed start date, so no return is shown
DSP Healthcare Fund · DSP Multi Cap Fund
Each scheme's direct-growth return over the dates filed for this manager, next to its category's average. Returns and averages are computed by this site from AMFI NAVs; they are not the fund house's figures. Past performance may not be sustained in future.
| Month | Schemes with a change | Stocks added | Stocks cut | Bought | Sold | Net |
|---|---|---|---|---|---|---|
| Oct 2026 | 2 | 14 | 5 | ₹226 cr | ₹112 cr | +₹114 cr |
| Sep 2026 | 2 | 6 | 9 | ₹69.2 cr | ₹206 cr | −₹137 cr |
| Aug 2026 | 2 | 9 | 6 | ₹272 cr | ₹125 cr | +₹147 cr |
| Jul 2026 | 2 | 22 | 5 | ₹666 cr | ₹57.3 cr | +₹609 cr |
| Jun 2026 | 2 | 10 | 7 | ₹262 cr | ₹306 cr | −₹43.6 cr |
| May 2026 | 2 | 9 | 9 | ₹104 cr | ₹268 cr | −₹164 cr |
| Apr 2026 | 2 | 4 | 8 | ₹39.1 cr | ₹103 cr | −₹63.6 cr |
| Mar 2026 | 1 | 8 | 5 | ₹119 cr | ₹38.3 cr | +₹80.3 cr |
| Feb 2026 | 2 | 8 | 4 | ₹83.1 cr | ₹51.9 cr | +₹31.2 cr |
| Jan 2026 | 2 | 6 | 3 | ₹27.0 cr | ₹11.3 cr | +₹15.8 cr |
| Dec 2025 | 2 | 8 | 4 | ₹105 cr | ₹27.0 cr | +₹78.2 cr |
| Nov 2025 | 2 | 8 | 6 | ₹112 cr | ₹99.3 cr | +₹13.0 cr |
Across the schemes this manager is named on today, by share count.
Changes seen in AMFI's documents
since 29 Sep 2026
Changes on this manager's schemes, by the date AMFI's document first showed them.
Added 14
14 stocks · largest 14 by value
| Stock | Schemes | Implied change, share count × price | Price 30 Oct 2026, 12‑month change |
|---|---|---|---|
| APOLLOHOSP | 1 | +₹58.5 cr | ₹8,448.00 ▲ +10.0% |
| THYROCARE | 1 | +₹44.6 cr | ₹456.30 ▼ −2.0% |
| SMT | 1 | +₹41.8 cr | — |
| ABBOTINDIA | 1 | +₹33.0 cr | ₹25,635.00 ▼ −11.6% |
| ERIS | 1 | +₹18.6 cr | ₹1,156.40 ▼ −27.3% |
| SYNGENE | 1 | +₹9.8 cr | ₹402.70 ▼ −38.1% |
| NAUKRI | 1 | +₹7.1 cr | ₹1,189.60 ▼ −13.7% |
| TIINDIA | 1 | +₹7.1 cr | ₹2,120.00 ▼ −29.9% |
| POLYCAB | 1 | +₹2.5 cr | ₹7,787.00 ▲ +1.1% |
| DODLA | 1 | +₹1.4 cr | ₹979.40 ▼ −24.2% |
| UTIAMC | 1 | +₹1.4 cr | ₹810.40 ▼ −35.0% |
| JLHL | 1 | +₹0.32 cr | ₹257.15 ▼ −19.0% |
| KOVAI | 1 | +₹0.20 cr | ₹5,816.00 ▲ +2.8% |
| UNICHEMLAB | 1 | +₹0.07 cr | ₹483.75 ▲ +2.7% |
Each scheme's change in shares at its month-end price, summed over this manager's schemes, Oct 2026.
Questions about Chirag Dagli
from the figures on this pageWhat stocks are in Chirag Dagli's portfolio?
The 2 schemes Chirag Dagli manages held 72 stocks worth ₹5,906 cr at Oct 2026 end. Largest: Cipla 6.0 %, Apollo Hospitals Enterprise 5.6 %, IPCA Laboratories 5.5 %, Gland Pharma 5.3 %, Sai Life Sciences 4.7 %. Cipla mutual fund holdings · Apollo Hospitals Enterprise mutual fund holdings · IPCA Laboratories mutual fund holdings
Which stocks did Chirag Dagli buy and sell in Oct 2026?
In Oct 2026, Chirag Dagli's schemes added to 14 stocks, largest Apollo Hospitals Enterprise (APOLLOHOSP), Thyrocare Technologies (THYROCARE), Sahajanand Medical Technologies (SMT); cut 5, largest Coforge (COFORGE), APL Apollo Tubes (APLAPOLLO), IPCA Laboratories (IPCALAB), by value at month-end prices.
Which mutual fund schemes does Chirag Dagli manage?
AMFI's scheme summary documents name Chirag Dagli (DSP Mutual Fund) for 2 schemes: DSP Healthcare Fund, DSP Multi Cap Fund. DSP Healthcare Fund portfolio · DSP Multi Cap Fund portfolio